IFNB1 and prostate cancer: Therefore, this study evaluated the use of bacterial CD and rabbit CE genes in gene-directed prodrug enzyme therapy, and assessed the effectiveness of a “double-punch system” involving the co-expression of CD and IFN-β for treating prostate cancer.